HRTX R&D to Revenue
Heron Therapeutics Inc · R&D to Revenue
HRTX R&D to Revenue
Latest reported7.17%period ending
HRTX Quarterly R&D/Revenue (0.00% → 7.17%)
Latest values, visible window
High-resolution chart · PNG
HRTX r&d to revenue history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 7.1736% | |
| 6.871% | |
| 9.2293% | |
| 9.0807% | |
| 7.8871% | |
| 5.8582% | |
| 7.7928% | |
| 13.6087% | |
| 12.3029% | |
| 13.291% | |
| 31.9867% | |
| 43.1316% | |
| 41.5906% | |
| 29.8362% | |
| 36.8223% | |
| 96.1893% | |
| 104.3576% | |
| 179.3494% | |
| 139.8063% | |
| 123.0951% | |
| 156.9888% | |
| 190.4086% | |
| 215.7389% | |
| 246.3411% | |
| 194.1239% | |
| 145.252% | |
| 137.608% | |
| 81.4283% | |
| 113.0009% | |
| 135.9787% | |
| 138.2991% | |
| 153.7501% | |
| 174.5616% | |
| 342.0161% | |
| 475.0522% | |
| 336.4909% | |
| 336.04% | |
| 919.163% | |
| 2,306.8804% | |
| 4,575.1891% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 69.2637% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 510.757% | |
| 288.8608% | |
| 839.1061% | |
| 439.0313% | |
| 356.6038% | |
| 967.2199% | |
| 1,163.9344% | |
| 126.9472% | |
| 20,771.4286% | |
| 25,625% | |
| 13,142.8571% | |
| 7,920.3125% | |
| 3,643.4211% | |
| 4,616.5414% | |
| 4,560.6061% | |
| 3,797.5207% | |
| 2,351.875% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 214.2659% | |
| 172.4757% | |
| 246.24% | |
| 133.9706% | |
| 191.6329% | |
| 172.9767% | |
| 226.2461% | |
| 257.2034% | |
| 167.0839% | |
| 146.2145% | |
| 209.0421% | |
| 199.0958% | |
| 73.3132% | |
| 139.5383% | |
| 149.8799% | |
| 120.9208% | |
| 168.4392% | |
| 205.1357% |